Davis Scott G. 4
4 · EKSO BIONICS HOLDINGS, INC. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Davis Scott G.
DirectorCEO
Transactions
- Sale
Common Stock
2025-11-10$4.80/sh−23,315$111,912→ 78,777 total
Holdings
- 373(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents shares sold by the Reporting Person on November 10, 2025 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in Form 4 filed with the Commission on November 7, 2025.
- [F2]These shares were sold in a single transaction at a price of $4.7990 per share.
- [F3]On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.